EP 2346825 A2 20110727 - MODULATORS OF P2X3 RECEPTOR ACTIVITY
Title (en)
MODULATORS OF P2X3 RECEPTOR ACTIVITY
Title (de)
MODULATOREN DER P2X3-REZEPTORAKTIVITÄT
Title (fr)
COMPOSÉS AMIDES, COMPOSITIONS ET UTILISATIONS DES COMPOSÉS ET COMPOSITIONS
Publication
Application
Priority
- US 2009005119 W 20090914
- US 11822808 P 20081126
- US 19258108 P 20080918
- US 18091509 P 20090525
Abstract (en)
[origin: WO2010033168A2] Compounds are provided according to formula (I), where A, B, W, X', L, R1, R3, R4b, and m' are as defined herein. Provided compounds and pharmaceutical compositions thereof are useful for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, pain, inflammation, cognitive disorders, anxiety, depression, and others.
IPC 8 full level
C07D 213/40 (2006.01); A61K 31/44 (2006.01); A61K 31/506 (2006.01); A61P 25/00 (2006.01); C07C 255/50 (2006.01); C07D 213/56 (2006.01); C07D 239/26 (2006.01); C07D 401/12 (2006.01); C07D 401/14 (2006.01); C07D 413/12 (2006.01)
CPC (source: EP US)
A61K 31/166 (2013.01 - EP US); A61K 31/40 (2013.01 - EP US); A61P 1/00 (2017.12 - EP); A61P 1/02 (2017.12 - EP); A61P 1/12 (2017.12 - EP); A61P 1/14 (2017.12 - EP); A61P 3/04 (2017.12 - EP); A61P 7/10 (2017.12 - EP); A61P 7/12 (2017.12 - EP); A61P 9/10 (2017.12 - EP); A61P 11/00 (2017.12 - EP); A61P 11/02 (2017.12 - EP); A61P 11/06 (2017.12 - EP); A61P 11/08 (2017.12 - EP); A61P 13/08 (2017.12 - EP); A61P 13/10 (2017.12 - EP); A61P 13/12 (2017.12 - EP); A61P 17/02 (2017.12 - EP); A61P 17/04 (2017.12 - EP); A61P 17/06 (2017.12 - EP); A61P 19/02 (2017.12 - EP); A61P 25/00 (2017.12 - EP); A61P 25/04 (2017.12 - EP); A61P 25/06 (2017.12 - EP); A61P 25/08 (2017.12 - EP); A61P 25/20 (2017.12 - EP); A61P 25/22 (2017.12 - EP); A61P 25/24 (2017.12 - EP); A61P 25/28 (2017.12 - EP); A61P 29/00 (2017.12 - EP); A61P 35/00 (2017.12 - EP); A61P 37/06 (2017.12 - EP); A61P 37/08 (2017.12 - EP); A61P 43/00 (2017.12 - EP); C07C 233/69 (2013.01 - US); C07C 233/70 (2013.01 - US); C07C 255/57 (2013.01 - EP US); C07D 213/40 (2013.01 - EP US); C07D 213/56 (2013.01 - EP US); C07D 227/04 (2013.01 - EP US); C07D 227/087 (2013.01 - EP US); C07D 239/26 (2013.01 - EP US); C07D 295/04 (2013.01 - EP US); C07D 295/10 (2013.01 - EP US); C07D 401/12 (2013.01 - EP US); C07D 401/14 (2013.01 - EP US); C07D 413/12 (2013.01 - EP US)
Citation (search report)
See references of WO 2010033168A2
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR
Designated extension state (EPC)
AL BA RS
DOCDB simple family (publication)
WO 2010033168 A2 20100325; WO 2010033168 A3 20101118; CA 2737038 A1 20100325; EP 2346825 A2 20110727; JP 2012502986 A 20120202; JP 5608655 B2 20141015; US 2011237578 A1 20110929; US 2014323532 A1 20141030; US 9133122 B2 20150915
DOCDB simple family (application)
US 2009005119 W 20090914; CA 2737038 A 20090914; EP 09736314 A 20090914; JP 2011527808 A 20090914; US 200913119947 A 20090914; US 201414327442 A 20140709